Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Santarus Inc. (SNTS)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
1 new
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: SNTS
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Comments on SNTS
Santarus' Zegrid Facing Back-to-Back FDA Approval Dates
[View article]
this was posted word for word on biomedreports.com i think im on to something? ugh dat sucks...
Comment by
Hustle617
Dec 2 12:10 pm
|
Rating:
0
0
AH: Shares of SNTS Explode! ]]]] +34% [[[[
[View instapost]
Thanks Justin! To top this, SNTS has another FDA action date on December 9th for Zegerid. Regards, Charlie
Comment by
lyme3m
Dec 2 10:30 am
|
Rating:
0
0
Santarus' Zegrid Facing Back-to-Back FDA Approval Dates
[View article]
Congratulations to all who followed this one. On the question about time between approval and launch, nobody really knows, but the...
More »
Comment by
R. Saito
Dec 1 18:17 pm
|
Rating:
0
0
Santarus, Depomed Poised to Gain from Anticipated Sales of Glumetza
[View article]
Sorry, here are the...
More »
Comment by
ThreeBrothersHealth.com
Nov 20 13:57 pm
|
Rating:
+1
0
Santarus, Depomed Poised to Gain from Anticipated Sales of Glumetza
[View article]
I am sorry, but this article is grossly incorrect and inaccurate. Even if glumetza commands the entire "branded metformin" market, it...
More »
Comment by
ThreeBrothersHealth.com
Nov 20 13:56 pm
|
Rating:
+1
0
Santarus' Zegrid Facing Back-to-Back FDA Approval Dates
[View article]
Why didn't OTC get approved initially? How long between approval and launch? With capsule and powder versions already available, how...
More »
Comment by
Tina L
Nov 20 11:14 am
|
Rating:
+1
0
RxNews Recap for Tuesday 11-10-09
[View instapost]
Thanks for the heads up. Just added him/her to my list!
Comment by
M. E. Garza
Nov 12 04:01 am
|
Rating:
0
0
RxNews Recap for Tuesday 11-10-09
[View instapost]
Oops! please white out, "...not only," in the above comment.
Comment by
Mayascribe
Nov 11 16:41 pm
|
Rating:
+1
0
RxNews Recap for Tuesday 11-10-09
[View instapost]
M.E.Garza: Thanks for the undate. Question: Are you aware that right here on SA someone is doing an incredible job concentrating all...
More »
Comment by
Mayascribe
Nov 11 16:40 pm
|
Rating:
+1
0
Santurus (SNTS): A Good Buy
[View instapost]
I agree. I think if it can penetrate $4, then it's on!
Comment by
Justin M. Hall
Nov 9 11:39 am
|
Rating:
+1
0
Santurus (SNTS): A Good Buy
[View instapost]
the 4.25 break will be huge....*check the chart*
Comment by
Hustle617
Nov 9 11:37 am
|
Rating:
+1
0
Extreme FDA Trades: 30 Stocks Under 5 Bucks
[View article]
Mike, Thanks for the article. What's your take on Neopharma (Neol.pk). I read on article on Biomedreports that there are many pending...
More »
Comment by
sdmy123
Oct 1 10:58 am
|
Rating:
0
0
Extreme FDA Trades: 30 Stocks Under 5 Bucks
[View article]
intranasal ketamine? really? Thanks for this info, this is interesting. I had no idea anyone was developing ketamine for this purpose. ...
More »
Comment by
drbob66
Sep 22 17:26 pm
|
Rating:
0
0
Pending FDA Decisions: 20 Extreme Trades
[View article]
Thanks mike, all your posts are big help, are you updating this list any time soon?, please let us know. Thanks again!
Comment by
santy
Sep 12 09:20 am
|
Rating:
0
0
Extreme FDA Trades: 30 Stocks Under 5 Bucks
[View article]
ok what is your take on biel now 8-25-09
Comment by
DuckThis
Aug 25 18:08 pm
|
Rating:
0
0
1
2
3
4
5
6
Next Page
Santarus' Zegrid Facing Back-to-Back FDA Approval Dates [View article]
AH: Shares of SNTS Explode! ]]]] +34% [[[[ [View instapost]
Santarus' Zegrid Facing Back-to-Back FDA Approval Dates [View article]
Santarus, Depomed Poised to Gain from Anticipated Sales of Glumetza [View article]
Santarus, Depomed Poised to Gain from Anticipated Sales of Glumetza [View article]
Santarus' Zegrid Facing Back-to-Back FDA Approval Dates [View article]
RxNews Recap for Tuesday 11-10-09 [View instapost]
RxNews Recap for Tuesday 11-10-09 [View instapost]
RxNews Recap for Tuesday 11-10-09 [View instapost]
Santurus (SNTS): A Good Buy [View instapost]
Santurus (SNTS): A Good Buy [View instapost]
Extreme FDA Trades: 30 Stocks Under 5 Bucks [View article]
Extreme FDA Trades: 30 Stocks Under 5 Bucks [View article]
Pending FDA Decisions: 20 Extreme Trades [View article]
Extreme FDA Trades: 30 Stocks Under 5 Bucks [View article]